Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide does not require mixing. Mounjaro — the UK brand — comes as a ready-to-use solution inside a pre-filled KwikPen; there is no powder, no diluent and no preparation step before injection. If you have encountered instructions online for mixing tirzepatide yourself, those refer to compounded or unlicensed products that fall outside the licensed supply chain the MHRA regulates. Understanding the difference protects you. Mounjaro is a prescription-only medicine, and a prescriber decides suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question is reasonable. Some GLP-1 medicines (particularly those used in research or compounded in the United States) do require reconstitution: adding sterile water to a lyophilised powder, drawing the result into a syringe, calculating a dose. Videos and forums describing this process are easy to find, and for someone new to injectable medicines, the distinction between compounded and licensed products is not obvious.
In the UK, the position is straightforward. Mounjaro, licensed by the MHRA for weight management and type 2 diabetes, arrives as a pre-filled pen containing a clear, ready-to-inject solution. Eli Lilly's KwikPen holds four weekly doses at the prescribed strength. You do not open it, you do not add anything to it, and no syringe is involved. The step-by-step Mounjaro instructions cover everything from checking the pen to rotating injection sites, and they confirm there is no preparation stage.
If a product you have seen marketed as tirzepatide requires mixing, it is not UK-licensed Mounjaro, and our guide to mixing tirzepatide explains exactly why that distinction matters and what the process involves for products that do require reconstitution. The MHRA's public warnings (including the raid of an illicit manufacturing site in Northampton in October 2025 producing counterfeit tirzepatide pens) make clear that unlicensed tirzepatide products circulate in the UK. Some have contained the wrong substances entirely. Sourcing through a GPhC-registered pharmacy, with a prescription issued after a genuine clinical assessment, is the only way to be certain of what you are injecting.
Before you use your pen for the first time, it is worth knowing what you are looking at. Each KwikPen is a single-use, multi-dose device containing 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg of tirzepatide in solution, whichever strength your prescriber has approved. The liquid inside should be clear to slightly yellow and free of particles. If it looks cloudy, discoloured or contains visible matter, do not inject it; contact your pharmacy.
There is no needle attached on arrival: you add a new needle before each dose and remove and dispose of it safely afterwards in a sharps container. Storage is in the fridge between 2 °C and 8 °C until the date on the label; for the exact permitted room-temperature window once removed from the fridge, the definitive reference is the Patient Information Leaflet inside your pack, or the Mounjaro SmPC on the eMC. Those figures can change between formulations, so the leaflet takes precedence over anything stated on a general website.
If you prefer to watch rather than read, a guided video walkthrough of the injection process covers each stage at a pace that makes it easy to follow alongside the pen in your hand. Many people find it settles nerves before the first dose.
This is the part worth pausing on. The appeal of compounded or online-sourced tirzepatide is usually price. Licensed Mounjaro has a list price; private clinics add consultation and dispensing costs on top, and for some people the total is a stretch. How Mounjaro pricing works in the UK explains the landscape honestly, including what changed after Eli Lilly revised its list price in September 2025.
A product that requires home mixing and costs significantly less is not a workaround, it is a different product, one whose sterility, concentration and contents you cannot verify. The MHRA's Yellow Card scheme allows anyone to report a suspected counterfeit or unsafe medicine; using it when something looks wrong protects other patients too.
You can verify whether any online pharmacy is GPhC-registered at the GPhC register. A legitimate pharmacy will always require a valid prescription before dispensing a prescription-only medicine, no exceptions. If a seller offers tirzepatide without one, that alone is reason to walk away.
The tirzepatide overview covers the medicine's mechanism, clinical evidence and licensing in full if you want the broader picture. For questions specific to administration, tirzepatide administration guidance addresses injection technique, site rotation and what to do if a dose is missed, always cross-referenced against your own prescriber's advice and your Patient Information Leaflet.
One practical question our prescribers hear regularly: what happens if a delivery falls on a bank holiday, or a pen runs low mid-month when payday is still a week off? The honest answer is that timing matters more than people expect, and building a small buffer into your order schedule is sensible. Mounjaro is taken once weekly on the same day each week; a gap or a missed dose is a conversation for your prescriber, not something to paper over by sourcing a pen from an unverified seller at short notice.
If you are already on treatment and want to understand how your current plan was put together, the FAQs cover common mid-treatment questions, and our aftercare team is available seven days a week. If you are considering starting and want to understand whether you are likely to be clinically suitable, who we are and how we work gives you a clear picture before any commitment. When you are ready, our prescribers are the right people to speak to.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.